The Centers for Medicare & Medicaid Services today issued a proposed rule that would revise regulations setting forth the appeals process that Medicare beneficiaries, providers and suppliers must follow in order to appeal adverse determinations regarding claims for benefits under Medicare Parts A and B and prescription drug coverage under Part D. The agency said the changes are intended to streamline and clarify the appeals process and reduce administrative burdens. 

Related News Articles

Headline
The AHA Sept. 17 urged the Department of Health and Human Services’ Office of Inspector General to further scrutinize policies and practices by certain…
Headline
The Centers for Medicare & Medicaid services Sept. 10 announced the opening of a 60-day public comment period regarding its proposed plan for new data…
Headline
Hospitals and health systems are seeing significant increases in administrative costs, including due to burdensome practices by commercial insurers that often…
Headline
The Centers for Medicare & Medicaid Aug. 15 announced it negotiated lower prices with drug makers for 10 high-cost, sole-source drugs, with the new prices…
Headline
The AHA, joined by five other national hospital associations, Aug. 14 filed an amicus brief urging the Supreme Court to correct the Department of Health and…
Headline
The AHA Aug. 13 commented to the Medicare Payment Advisory Commission in anticipation of the commission’s 2024-2025 cycle. The AHA urged MedPAC to carefully…